Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects

ClinicalTrials.gov ID: NCT00734435

Public ClinicalTrials.gov record NCT00734435. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Proof of Concept, Multi-Center, Randomized, Double-Blind, Parallel, Placebo-Controlled, Study of Zonisamide Sustained Release (SR) 360 mg Versus Placebo in the Prevention of Weight Gain Associated With Olanzapine Therapy for Psychosis

Study identification

NCT ID
NCT00734435
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Orexigen Therapeutics, Inc
Industry
Enrollment
26 participants

Conditions and interventions

Interventions

  • zonisamide SR plus olanzapine Drug
  • Placebo plus olanzapine Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2008
Primary completion
Nov 30, 2008
Completion
Nov 30, 2008
Last update posted
Nov 28, 2012

2008

United States locations

U.S. sites
9
U.S. states
6
U.S. cities
9
Facility City State ZIP Site status
Synergy Research National City California 91950
UCI Medical Center Orange California 92868
CNRI San Diego San Diego California 92126
Florida Clincal Research Center Bradenton Florida 34208
Florida Clinical Research Center Maitland Florida 34208
Atlanta Center for Medical Research Atlanta Georgia 30308
American Medical Research Oak Brook Illinois 60523
Larue D. Carter Hospital Indianapolis Indiana 46222
Brooklyn Medical Institute Brooklyn New York 11223

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00734435, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 28, 2012 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00734435 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →